Point State Capital LP Medtronic PLC Transaction History

Point State Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $3.52 Million - $3.93 Million	-35,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$99.53 - $127.75 $497,650 - $638,750	-5,000 Reduced 12.5%	35,000 $3.62 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $859,250 - $946,189	-7,000 Reduced 14.89%	40,000 $5.01 Million
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $8 Million - $8.9 Million	-67,700 Reduced 59.02%	47,000 $5.83 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $7.27 Million - $7.83 Million	65,400 Added 132.66%	114,700 $13.6 Million
Q4 2020 Feb 16, 2021	SELL	$100.57 - $117.14 $573,249 - $667,698	-5,700 Reduced 10.36%	49,300 $5.78 Million
Q3 2020 Nov 16, 2020	BUY	$90.13 - $108.78 $4.96 Million - $5.98 Million	55,000 New	55,000 $5.72 Million

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.